Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Our Initiatives
Explore more Johnson & Johnson sites:
A graphic of the flag of Australia alt
A graphic of the flag of Argentina alt
A graphic of the flag of Brazil alt
A graphic of the national flag of Canada alt
A graphic of the flag of Chile alt
A graphic of the national flag of the People's Republic of China alt
A graphic of the national flag of Colombia alt
A graphic of the national flag of Ecuador alt
A graphic of the flag of Germany alt
A graphic of the national flag of India alt
A graphic of the national flag of Japan alt
A graphic of the flag of Mexico alt
A graphic of the flag of Paraguay alt
A graphic of the flag of Peru alt
A graphic of the flag of Russia alt
Switzerland
A graphic of the flag of Switzerland alt
A graphic of the national flag of Uruguay alt
A graphic of the flag of Venezuela alt
Page logo
Financial
Johnson & Johnson Announces Dividend Increase of 5.0%
Johnson & Johnson Announces Dividend Increase of 5.0%

New Brunswick, N.J. (April 27, 2017) – Johnson & Johnson today announced that its Board of Directors has declared a 5.0% increase in the quarterly dividend rate, from $0.80 per share to $0.84 per share. The increase was announced this morning at the Annual Meeting of Shareholders in New Brunswick, N.J.

“In recognition of our 2016 results, strong financial position and confidence in the future of Johnson & Johnson, the Board has voted to increase the quarterly dividend for the 55th consecutive year,” said Alex Gorsky, Chairman and Chief Executive Officer of the company.

At the new rate, the indicated dividend on an annual basis is $3.36 per share compared to the previous rate of $3.20 per share. The next quarterly dividend is payable on June 13, 2017 to shareholders of record as of the close of business on May 30, 2017. The ex-dividend date is May 25, 2017.

About Johnson & Johnson

Caring for the world, one person at a time…inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 130,800 employees at more than 250 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

Press Contact:

Ernie Knewitz
(732) 524-6623
(917) 697-2318 (M)

Amy Jo Meyer
732-524-6678
908-616-6250 (M)

Investor Contacts:
Joseph J. Wolk
(732) 524-1142

Lisa Romanko
(732) 524-2034

# # #

This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
Close cookie banner icon
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue